Intriguingly, drug-tolerant persister cancer cells or mesenchymal cancer cells resistance to therapyare vulnerable to ferroptosis, which is likely to be associated with their dependence on GPX4 function (Hangauer et al., 2017; Viswanathan et al., 2017). Here, GPX4 is linked to cancer.